ESG commitments have become central to biotechnology companies' relationships with institutional investors, employees, and the public. Access to medicines — ensuring that innovative biotechnology therapies reach patients in low- and middle-income countries at affordable prices — is the most commercially and reputationally consequential ESG issue for the industry. Novo Nordisk's Changing Diabetes initiative, Gilead's HIV access programs in Sub-Saharan Africa, and Teva's longstanding generic drug access infrastructure represent the leading access to medicines programs. Environmental sustainability — reducing the carbon footprint of biomanufacturing, pharmaceutical cold chain logistics, and packaging — is an increasingly important ESG priority.
Topics Covered
• Access to Medicines Programs
• Voluntary Licensing and Technology Transfer
• Environmental Sustainability in Biomanufacturing
• ESG Reporting Frameworks
• Investor ESG Requirements
• Leading Company ESG Programs
• Regulatory ESG Disclosure
• Competitive Landscape
Table of Contents
1. Executive Summary
2. Market Overview
3. Access to Medicines Programs
4. Voluntary Licensing and Technology Transfer
5. Environmental Sustainability in Biomanufacturing
6. ESG Reporting Frameworks
7. Investor ESG Requirements
8. Leading Company ESG Programs
9. Regulatory ESG Disclosure
10. Competitive Landscape
11. Regional Market Analysis
12. Strategic Conclusions
13. Appendix
List of Tables
Table 1. Market Overview and Key Data 2025
Table 2. Access to Medicines Programs
Table 3. Voluntary Licensing and Technology Transfer
Table 4. Environmental Sustainability in Biomanufacturing
Table 5. ESG Reporting Frameworks
Table 6. Investor ESG Requirements
Table 7. Leading Company ESG Programs
Table 8. Regulatory ESG Disclosure
Table 9. Competitive Landscape
Table 10. Leading Companies — Strategy Assessment 2025
Table 11. Pipeline Assessment 2025
Table 12. Key Risks and Mitigation Strategies
Companies Profiled
Amgen
Gilead Sciences
Regeneron
Biogen
Vertex
BioNTech
Moderna
Genentech
CSL Behring
